Global Artificial Blood Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1     Primary Research

1.3.2     Secondary Research

1.3.3     In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Artificial Blood Market Year-on-Year Growth, 2020 – 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1     Drivers

3.5.1.1     Impact Analysis

3.5.2     Restraints

3.5.2.1     Impact Analysis

3.5.3     Opportunities

Chapter 4        Global Artificial Blood Market by Source: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Human Blood

4.2.1   Current Trend and Analysis

4.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Animal Blood

4.3.1   Current Trend and Analysis

4.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Recombinant Technology

4.4.1   Current Trend and Analysis

4.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Artificial Blood Market by Type: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Per fluorocarbon Emulsions

5.2.1   Current Trend and Analysis

5.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Hemoglobin Based Oxygen Carrier Diabetes

5.3.1   Current Trend and Analysis

5.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Artificial Blood Market by Application: Market Size and Forecast, 2019 - 2028

6.1  Overview

6.2  Global Potential Artificial Blood Market

6.2.1   Current Trend and Analysis

6.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3   Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 7        Global Artificial Blood Market by Geography: Market Size and Forecast, 2019 - 2028 

7.1  Overview

7.1.1   Global Artificial Blood Market Year-on-Year Growth, by region 2020 – 2028 (%)

7.2  North America

7.2.1   Current Trend and Analysis

7.2.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3   U.S.

7.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3.2        By Source

7.2.3.3        By Type

7.2.3.4        By Application

7.2.4   Canada

7.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.4.2        By Source

7.2.4.3        By Type

7.2.4.4        By Application

7.2.5   Mexico

7.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.5.2        By Source

7.2.5.3        By Type

7.2.5.4        By Application

7.3    Europe

7.3.1   Current Trend and Analysis

7.3.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3   UK

7.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3.2        By Source

7.3.3.3        By Type

7.3.3.4        By Application

7.3.4   Russia

7.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.4.2        By Source

7.3.4.3        By Type

7.3.4.4        By Application

7.3.5   France

7.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.5.2        By Source

7.3.5.3        By Type

7.3.5.4        By Application

7.3.6   Italy

7.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.6.2        By Source

7.3.6.3        By Type

7.3.6.4        By Application

7.3.7   Germany

7.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.7.2        By Source

7.3.7.3        By Type

7.3.7.4        By Application

7.3.8   Rest of Europe

7.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.8.2        By Source

7.3.8.3        By Type

7.3.8.4        By Application

7.4    Asia-Pacific

7.4.1   Current Trend and Analysis

7.4.2   Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3   China

7.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3.2        By Source

7.4.3.3        By Type

7.4.3.4        By Application

7.4.4   India

7.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.4.2        By Source

7.4.4.3        By Type

7.4.4.4        By Application

7.4.5   Japan

7.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.5.2        By Source

7.4.5.3        By Type

7.4.5.4        By Application

7.4.6   Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.6.2        By Source

7.4.6.3        By Type

7.4.6.4        By Application

7.5    RoW

7.5.1   Current Trend and Analysis

7.5.2   Market Size and Forecast

7.5.3   South America

7.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.3.2        By Source

7.5.3.3        By Type

7.5.3.4        By Application

7.5.4   Middle East

7.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.4.2        By Source

7.5.4.3        By Type

7.5.4.4        By Application

7.5.5   Africa

7.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.5.2        By Source

7.5.5.3        By Type

7.5.5.4        By Application

Chapter 8        Company Profiles

8.1  Alliance Pharmaceutical Corp.

8.1.1     Company Overview

8.1.2     Product Portfolio

8.1.3     Business Strategies

8.1.4     Financials

8.1.5     Recent Developments

8.2  Baxter Healthcare Corp.

8.2.1     Company Overview

8.2.2     Product Portfolio

8.2.3     Business Strategies

8.2.4     Financials

8.2.5     Recent Developments

8.3  Biopure Corp.

8.3.1     Company Overview

8.3.2     Product Portfolio

8.3.3     Business Strategies

8.3.4     Financials

8.3.5     Recent Developments

8.4  Fluoro2 Therapeutics, Inc.

8.4.1     Company Overview

8.4.2     Product Portfolio

8.4.3     Business Strategies

8.4.4     Financials

8.4.5     Recent Developments

8.5  NorthField Laboratories Inc.

8.5.1     Company Overview

8.5.2     Product Portfolio

8.5.3     Business Strategies

8.5.4     Financials

8.5.5     Recent Developments

8.6  Nuvox Pharma LLC.

8.6.1     Company Overview

8.6.2     Product Portfolio

8.6.3     Business Strategies

8.6.4     Financials

8.6.5     Recent Developments

8.7  Prolong Pharmaceutical LLC.

8.7.1     Company Overview

8.7.2     Product Portfolio

8.7.3     Business Strategies

8.7.4     Financials

8.7.5     Recent Developments

8.8  Sangart Inc.

8.8.1     Company Overview

8.8.2     Product Portfolio

8.8.3     Business Strategies

8.8.4     Financials

8.8.5     Recent Developments

8.9  Sanguine Biosciences

8.9.1     Company Overview

8.9.2     Product Portfolio

8.9.3     Business Strategies

8.9.4     Financials

8.9.5     Recent Developments

8.10       Tenax Therapeutics Inc.

8.10.1   Company Overview

8.10.2   Product Portfolio

8.10.3   Business Strategies

8.10.4   Financials

8.10.5   Recent Developments

8.11       Therapure Biopharma Inc.

8.11.1   Company Overview

8.11.2   Product Portfolio

8.11.3   Business Strategies

8.11.4   Financials

8.11.5   Recent Developments